If you need more lookups,
subscriptions start at $34 USD/month.
Sofia Buch Location
Copenhagen, DK
Sofia Buch Work
2026 -now CEO @
2025 -now Strategic Advisor @
2021 -2026 Vice President for Cell Therapy CMC at Novo Nordisk @
2018 -2026 Vice President for Stem Cell CMC and Manufacturing @
2017 -2019 Project Vice President for stem cell projects @
2015 -2017 Vice President for Recombinant Technologies @
2014 -2015 Vice President for Yeast Protein Technology @
2013 -2014 Senior Director for Protein Chemistry @
2013 -2014 Project Director @
2011 -2013 Director @
2010 -2011 Team leader @
2006 -2010 Research Scientist @
Sofia Buch Education
Linköping University
Doctor of Philosophy (Ph.D.), Molecular Biotechnology (Molecular Biotechnology)
2000-2005
Linköping University
Master of Science (M.Sc.), Chemistry (Chemistry)
1996-2000
Sofia Buch Skills
Protein Purification
Biotechnology
Biochemistry
Business Development
Mass Spectrometry
Strategic Planning
HPLC
Project Planning
Lc Ms
Protein Chemistry
Drug Discovery
Sofia Buch Summary
Sofia Buch, based in Copenhagen, DK, is currently a CEO at ArgusEye. Sofia Buch brings experience from previous roles at Nordic Cell Therapy Group and Novo Nordisk. Sofia Buch holds a 2000 - 2005 Doctor of Philosophy (Ph.D.), Molecular Biotechnology in Molecular Biotechnology @ Linköping University. With a robust skill set that includes Protein Purification, Biotechnology, Biochemistry, Business Development, Mass Spectrometry and more. Sofia Buch has 2 emails on RocketReach.
Looking for a different Sofia Buch?
Find contact details for 700 million professionals.